Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Internet Explorer is no longer a supported browser.

This website may not display properly with Internet Explorer. For the best experience, please use a more recent browser such as the latest versions of Google Chrome, Microsoft Edge, and/or Mozilla Firefox. Thank you.

Your Environment. Your Health.

Progress Reports: University of North Carolina-Chapel Hill: Development and Application of Biomarkers of Exposure

Superfund Research Program

Development and Application of Biomarkers of Exposure

Project Leader: Stephen M. Rappaport (University of California-Berkeley)
Grant Number: P42ES005948
Funding Period: 1995 - 2011

Learn More About the Grantee

Visit the grantee's eNewsletter page Visit the grantee's Twitter page Visit the grantee's Video page

Progress Reports

Year:   2009  2008  2007  2006  2005  2004  2003  2002  2001  2000  1999  1998  1997  1996  1995 

The major accomplishments during the last year involved investigation of biomarkers of exposure to benzene which is a ubiquitous environmental contaminant. Although benzene is known to cause cancer in both humans and rodents, the mechanism of carcinogenesis remains elusive. The complexity of the metabolism of benzene and the myriad of effects that the various metabolites exert have precluded the formulation of a clear model of genotoxicity. The liver is the primary site of metabolism of benzene. However, bone marrow, the target tissue in humans, contains enzymes which are capable of either producing DNA-reactive species or activating those produced elsewhere.

The work to determine the mechanism by which benzene induces genotoxicity in the bone marrow has focused largely on the phenolic metabolites, phenol, catechol and hydroquinone; the latter can be oxidized by bone-marrow enzymes to the genotoxic species, 1,2- and 1,4-benzoquinone, respectively. Although there is extensive evidence that these phenolic metabolites are toxic, questions have emerged concerning the specific roles of these species in producing human leukemia. For example, levels of phenol, catechol and hydroquinone in the blood and urine of workers have been found to correlate poorly with exposure to benzene, especially at lower air concentrations. This motivated researchers to develop a new assay to measure protein adducts of another benzene metabolite, benzene oxide, in blood proteins of persons exposed to benzene. The new assay is considerably more sensitive and simpler than previous assays, and opens the possibility for use in large-scale epidemiological investigations. The new method for measuring benzene oxide adducts was applied to hemoglobin from 20 benzene-exposed workers (median: 31 ppm benzene) and 20 unexposed controls in Shanghai, China, as part of a larger cross-sectional study of benzene biomarkers conducted by the National Cancer Institute. Preliminary analyses show that median benzene oxide-hemoglobin adduct levels increased with exposure to benzene. This is the first direct evidence that benzene oxide adducts of Hb are produced in humans.

to Top